000			01513 a2200421 4500
005			20250513145138.0
264		0	_c19980827
008			199808s 0 0 eng d
022			_a0950-9240
024	7		_a10.1038/sj.jhh.1000634 _2doi
040			_aNLM _beng _cNLM
100	1		_aNishikawa, K
245	0	0	_aAngiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage. _h[electronic resource]
260			_bJournal of human hypertension _cMay 1998
300			_a301-9 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAngiotensin Receptor Antagonists
650	0	4	_aAnimals
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aBenzimidazoles _xtherapeutic use
650	0	4	_aBiphenyl Compounds _xtherapeutic use
650	0	4	_aCardiovascular Diseases _xprevention & control
650	0	4	_aCerebrovascular Disorders _xprevention & control
650	0	4	_aDisease Models, Animal
650	0	4	_aHypertension _xprevention & control
650	0	4	_aLosartan _xtherapeutic use
650	0	4	_aMale
650	0	4	_aNephrectomy
650	0	4	_aRats
650	0	4	_aRats, Inbred SHR
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aRats, Wistar
650	0	4	_aReceptor, Angiotensin, Type 1
650	0	4	_aReceptor, Angiotensin, Type 2
650	0	4	_aTetrazoles
773	0		_tJournal of human hypertension _gvol. 12 _gno. 5 _gp. 301-9
856	4	0	_uhttps://doi.org/10.1038/sj.jhh.1000634 _zAvailable from publisher's website
999			_c9621712 _d9621712